Inhaled treprostinil
Showing 1 - 25 of 2,156
Progressive Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic
Not yet recruiting
- Progressive Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
- (no location specified)
Jul 5, 2023
Pulmonary Hypertension, Interstitial Lung Disease Trial (LIQ861)
Not yet recruiting
- Pulmonary Hypertension
- Interstitial Lung Disease
- LIQ861
- (no location specified)
Nov 10, 2023
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial (Inhaled Treprostinil)
Available
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- (no location specified)
Oct 5, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in Kissimmee, Kansas City, Chesterfield (Inhaled Treprostinil,
Enrolling by invitation
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Inhaled Treprostinil
- Treprostinil Ultrasonic Nebulizer
-
Kissimmee, Florida
- +2 more
Jul 19, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
- (no location specified)
Feb 15, 2022
Pulmonary Arterial Hypertension, Interstitial Lung Disease, Healthy Adults Trial in Rochester (Treprostinil, Right Heart
Recruiting
- Pulmonary Arterial Hypertension
- +2 more
- Treprostinil
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 9, 2023
Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease Trial in Gainesville (Inhaled Treprostinil)
Recruiting
- Sarcoidosis
- +2 more
- Inhaled Treprostinil
-
Gainesville, FloridaUniversity of Florida, Division of Pulmonary and Critical Care M
Nov 12, 2021
Pulmonary Hypertension, COPD Trial in Israel, United States (Inhaled treprostinil solution)
Terminated
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled treprostinil solution
-
Birmingham, Alabama
- +29 more
Jan 5, 2023
Pulmonary Arterial Hypertension Trial in Nancy, Le Kremlin-Bicêtre, Gießen (Inhaled dry powder treprostinil (LIQ861))
Terminated
- Pulmonary Arterial Hypertension
- Inhaled dry powder treprostinil (LIQ861)
-
Nancy, Vandoeuvre Les Nancy, France
- +2 more
Sep 3, 2021
Pulmonary Arterial Hypertension Trial in Phoenix (L606 inhalation suspension)
Recruiting
- Pulmonary Arterial Hypertension
- L606 inhalation suspension
-
Phoenix, ArizonaArizona Pulmonary Specialists
Jan 26, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in United States (Placebo, Inhaled Treprostinil, Treprostinil
Recruiting
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
-
Birmingham, Alabama
- +55 more
Aug 16, 2022
Pulmonary Hypertension, COPD Trial in Worldwide (Inhaled treprostinil solution, Placebo solution)
Terminated
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled treprostinil solution
- Placebo solution
-
Birmingham, Alabama
- +75 more
Jan 5, 2023
Primary Pulmonary Hypertension Trial in United States (LIQ861 Inhaled Treprostinil)
Active, not recruiting
- Primary Pulmonary Hypertension
- LIQ861 Inhaled Treprostinil
-
Phoenix, Arizona
- +24 more
Aug 26, 2021
Congenital Heart Disease Trial in Cincinnati (Treprostinil, Placebo)
Terminated
- Congenital Heart Disease
- Treprostinil
- Placebo
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 13, 2020
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States
Completed
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- Placebo
-
Birmingham, Alabama
- +96 more
Jul 21, 2022
Primary Pulmonary Hypertension Trial in United States (LIQ861 Inhaled Treprostinil)
Completed
- Primary Pulmonary Hypertension
- LIQ861 Inhaled Treprostinil
-
Phoenix, Arizona
- +37 more
Nov 5, 2020
Pulmonary Vascular Disease Trial in Durham (Hyperpolarized 129Xenon gas)
Recruiting
- Pulmonary Vascular Disease
- Hyperpolarized 129Xenon gas
-
Durham, North CarolinaDuke University Medical Center
Oct 3, 2022
Pulmonary Arterial Hypertension Trial in United States (Treprostinil Inhalation Powder)
Active, not recruiting
- Pulmonary Arterial Hypertension
- Treprostinil Inhalation Powder
-
Birmingham, Alabama
- +18 more
Nov 2, 2022
Single Ventricle Trial in Palo Alto (Treprostinil)
Terminated
- Single Ventricle
-
Palo Alto, CaliforniaLucile Packard Children's Hospital, Stanford
Mar 8, 2022
Pulmonary Arterial Hypertension Trial in Austin (drug, device, other)
Completed
- Pulmonary Arterial Hypertension
- L606 (Liposomal Treprostinil) Inhalation Solution 51ug
- +2 more
-
Austin, TexasPPD
Dec 21, 2020
Patient Global Impression Questions for Activity-Induced
Completed
- Pulmonary Arterial Hypertension
- Treprostinil
- Non-Treprostinil PAH Medications
-
Birmingham, Alabama
- +9 more
Feb 26, 2021
Persistent Pulmonary Hypertension of the Newborn Trial in United States (IV Remodulin, Placebo)
Recruiting
- Persistent Pulmonary Hypertension of the Newborn
- IV Remodulin
- Placebo
-
Phoenix, Arizona
- +22 more
Apr 13, 2022
Pulmonary Arterial Hypertension Trial in Israel, United States (Beraprost Sodium 314d Modified Release Tablets, Placebo)
Completed
- Pulmonary Arterial Hypertension
- Beraprost Sodium 314d Modified Release Tablets
- Placebo
-
Birmingham, Alabama
- +74 more
Jul 20, 2020
Pulmonary Arterial Hypertension Trial in Montreal (Lidocaine, Placebo)
Terminated
- Pulmonary Arterial Hypertension
- Lidocaine
- Placebo
-
Montreal, Quebec, CanadaJewish General Hospital
Jan 30, 2023
Healthy Volunteers Trial in Austin (Treprostinil Palmitil Inhalation Powder, Placebo)
Completed
- Healthy Volunteers
- Treprostinil Palmitil Inhalation Powder
- Placebo
-
Austin, TexasUSA001
Oct 16, 2023